文献速递血液净化与透析

血液透析患者接种疫苗后COVID-19的严重程度:一项观察性队列研究

Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study.
PubMed 文献 · Clin J Am Soc Nephrol · 2022-01-01

这项多中心观察性研究分析了伦敦血液透析人群中1323例SARS-CoV-2感染者,其中1047例未接种、86例接种第一剂后、190例接种第二剂后感染。调整年龄、合并症和时间段后,既往两剂疫苗接种与未接种者相比,入院风险降低75%(95%CI 56至86),死亡减少88%(95%CI 70至95)。

要点

  • 透析患者感染SARS-CoV-2后多数为轻型,但515例(39%)住院、172例(13%)死亡。
  • 调整年龄、合并症和时间段后,两剂疫苗接种者较未接种者入院风险降低75%(95%CI 56至86)、死亡减少88%(95%CI 70至95)。
  • 65岁以上或接种后时间延长未见保护力丧失,不同疫苗类型间未见差异。

核心结论

  • 这些数据表明,透析患者感染SARS-CoV-2后,接种疫苗可大幅降低重症COVID-19风险。

研究设计与样本

  • 多中心观察性研究,纳入伦敦血液透析人群中在BNT162b2和AZD1222疫苗推广期间接受监测PCR检测者,识别所有SARS-CoV-2阳性者。
  • 使用混合效应逻辑回归模型按预测变量(包括疫苗接种状态)分析临床结局。
  • 在基础人群的一个亚组中,使用以疫苗接种状态为时间变化协变量的Cox比例风险模型分析感染风险。

主要发现

  • 在1323例不同族裔(亚洲/其他30%、黑人38%、白人32%)的SARS-CoV-2感染者中,1047例(79%)未接种、86例(7%)在首剂接种后感染、190例(14%)在第二剂接种后感染。
  • 多数患者病程轻微,但515例(39%)住院、172例(13%)死亡。
  • 年龄较大、糖尿病和免疫抑制与更高的疾病严重程度相关。
  • 在调整年龄、合并症和时间段的回归模型中,既往两剂疫苗接种与未接种者相比,入院风险降低75%(95%CI 56至86),死亡减少88%(95%CI 70至95)。
  • 65岁以上患者或接种后时间延长未见保护力丧失,不同疫苗类型间未见差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Patients receiving hemodialysis are at high risk from coronavirus disease 2019 (COVID-19) and demonstrate impaired immune responses to vaccines. There have been several descriptions of their immunologic responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, but few studies have described the clinical efficacy of vaccination in patients on hemodialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a multicenter observational study of the London hemodialysis population undergoing surveillance PCR testing during the period of vaccine rollout with BNT162b2 and AZD1222, all of those positive for SARS-CoV-2 were identified. Clinical outcomes were analyzed according to predictor variables, including vaccination status, using a mixed effects logistic regression model. Risk of infection was analyzed in a subgroup of the base population using a Cox proportional hazards model with vaccination status as a time-varying covariate. RESULTS: SARS-CoV-2 infection was identified in 1323 patients of different ethnicities (Asian/other, 30%; Black, 38%; and White, 32%), including 1047 (79%) unvaccinated, 86 (7%) after first-dose vaccination, and 190 (14%) after second-dose vaccination. The majority of patients had a mild course; however, 515 (39%) were hospitalized, and 172 (13%) died. Older age, diabetes, and immune suppression were associated with greater illness severity. In regression models adjusted for age, comorbidity, and time period, prior two-dose vaccination was associated with a 75% (95% confidence interval, 56 to 86) lower risk of admission and 88% (95% confidence interval, 70 to 95) fewer deaths compared with unvaccinated patients. No loss of protection was seen in patients over 65 years or with increasing time since vaccination, and no difference was seen between vaccine types. CONCLUSIONS: These data demonstrate a substantially lower risk of severe COVID-19 after vaccination in patients on dialysis who become infected with SARS-CoV-2.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ashby DR, Caplin B, Corbett RW, et al. Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study. Clin J Am Soc Nephrol. 2022. PMID: 35649718. doi:10.2215/CJN.16621221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。